MedPath

Association between cardiovascular risk and moderate-severe obstructive sleep apnea in Chile

Not Applicable
Conditions
Obstructive sleep apnea
Nervous System Diseases
Sleep apnoea
Registration Number
ISRCTN62293645
Lead Sponsor
Clinica Las Condes
Brief Summary

2021 Interim results article in https://www.ncbi.nlm.nih.gov/pubmed/32232718 oximetric parameter sub-analysis results (added 03/04/2020) 2023 Interim results article in https://pubmed.ncbi.nlm.nih.gov/37568362/ (added 04/09/2023) 2021 Interim results article in https://pubmed.ncbi.nlm.nih.gov/34217682/ (added 04/09/2023) 2021 Interim results article in https://pubmed.ncbi.nlm.nih.gov/33394326/ (added 04/09/2023) 2020 Interim results article in https://pubmed.ncbi.nlm.nih.gov/32780496/ (added 04/09/2023) 2020 Interim results article in https://pubmed.ncbi.nlm.nih.gov/32771926/ (added 04/09/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
3000
Inclusion Criteria

1. Participants aged >18 years
2. Referred for the sleep study because of the clinical suspicion of OSA (snoring symptoms, apneas observed by bed partner or excessive daytime sleepiness or major cardiovascular comorbidities)

Exclusion Criteria

1. Participants with other sleep disorders such as periodic limb movements of sleep (PLMS), NREM and arousal, REM and hypoxia, arousal and poor sleep
2. Participants who refuse to sign the consent form

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. All-cause mortality measured through a review of the national register database (https://www.registrocivil.cl) at 3, 5 and 10 years<br>2. Cardiovascular mortality measured through a review of the national register database (https://www.registrocivil.cl) at 3, 5 and 10 years
Secondary Outcome Measures
NameTimeMethod
1. New onset of hypertension measured by either medical record or telephone consultation at 5 and 10 years<br>2. New onset of T2DM measured by either medical record or telephone consultation at 5 and 10 years<br>3. New onset of CHD measured by either medical record or telephone consultation at 5 and 10 years<br>4. New onset of atrial fibrillation measured by either medical record or telephone consultation at 5 and 10 years
© Copyright 2025. All Rights Reserved by MedPath